Evidence map›Paper›PMID 37999531›Full record

ArticleToxics2023

Evaluation of Gold Complexes to Address Bacterial Resistance, Quorum Sensing, Biofilm Formation, and Their Antiviral Properties against Bacteriophages.

Ana Marques, Sónia A C Carabineiro, Manuel Aureliano, Leonor Faleiro

Abstract read
In one paragraph

Article in Toxics, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Review
  2. Review
  3. Anti-staphylococcal activity of the auranofin-analogous PEtFrontiers in cellular and infection microbiology · 2026
    Article
  4. Article
  5. Frontiers in cellular and infection microbiology · 2026
    Article
  6. Review
  7. An organometallic hybrid antibiotic of metronidazole with a Gold(I) N-Heterocyclic Carbene overcomes metronidazole resistance in Clostridioides difficile.Journal of biological inorganic chemistry : JBIC : a publication of the Society of Biological Inorganic Chemistry · 2024
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Ana MarquesFaculdade de Ciências e Tecnologia, Universidade do Algarve, Campus de Gambelas, 8005-139 Faro, Portugal.
Sónia A C CarabineiroLAQV-REQUIMTE, Department of Chemistry, NOVA School of Science and Technology, Universidade NOVA de Lisboa, 2829-516 Caparica, Portugal.ORCID 0000-0001-9913-4671
Manuel AurelianoFaculdade de Ciências e Tecnologia, Universidade do Algarve, Campus de Gambelas, 8005-139 Faro, Portugal.ORCID 0000-0003-4858-3201
Leonor FaleiroFaculdade de Ciências e Tecnologia, Universidade do Algarve, Campus de Gambelas, 8005-139 Faro, Portugal.ORCID 0000-0002-3878-6948

Funding

Fundação para a Ciência e Tecnologia CEEC-INST/00102/2018Fundação para a Ciência e Tecnologia FCT/MCTES (UIDB/50006/2020Fundação para a Ciência e Tecnologia LA/P/0101/2020Fundação para a Ciência e Tecnologia UIDB/04326/2020Fundação para a Ciência e Tecnologia UIDP/04326/2020Fundação para a Ciência e Tecnologia UIDP/5006/2020
6 · The paper itself

Abstract

The worldwide increase in antibiotic resistance poses a significant challenge, and researchers are diligently seeking new drugs to combat infections and prevent bacterial pathogens from developing resistance. Gold (I and III) complexes are suitable for this purpose. In this study, we tested four gold (I and III) complexes, (

Indexed as

1,3-bis(2,6-diisopropylphenyl) imidazole-2-ylidene Au(I) chlorideantibacterialantibiofilmantibiotic resistanceanti-quorum sensingantiviralchlorotrimethylphosphinegold (I)chlorotriphenylphosphinegold (I)dichloro (2-pyridinecarboxylate) Au (III)gold complexes

Identifiers

PMID37999531
PMCPMC10674251

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.